56
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration

, , &
Pages 1073-1082 | Published online: 13 Jul 2012

References

  • StorkebaumELambrechtsDCarmelietPVEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotectionBio Essays200426943954
  • NishijimaKNgYSZhongLVascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injuryAm J Pathol2007171536717591953
  • BrownDMKaiserPKMichelsMRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med20063551432144417021319
  • RosenfeldPJBrownDMHeierJSMARINA study group: ranibizumab for neovascular age-related macular degenerationN Engl J Med20063551419143117021318
  • BrownDMMichelsMKaiserPKANCHOR study group: ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR studyOphthalmology2009116576519118696
  • MitchellPKorobelnikJFLazettaPRanibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trialsBr J Ophthalmol20109421319443462
  • Van WijngaardenPCosterDJWilliamsKAInhibitors of ocular neovascularization: promises and potential problemsJAMA20052931509151315784876
  • ViswanathanSFrishmanLJRobsonJGThe photopic negative response of the macaque electroretinogram: reduction by experimental glaucomaInvest Ophthalmol Vis Sci1999401124113610235545
  • ViswanathanSFrishmanLJRobsonJGWalterJWThe photopic negative response of the flash electroretinogram in primary open angle glaucomaInvest Ophthalmol Vis Sci20014251452211157891
  • GotohYMachidaSTazawaYSelective loss of the photopic negative response in patients with optic nerve atrophyArch Ophthalmol200412234134615006846
  • RangaswamyNVFrishmanLJDorotheoEUPhotopic ERGs in patients with optic neuropathies: comparison with primate ERGs after pharmacological blockade of inner retinaInvest Ophthalmol Vis Sci2004453827383715452095
  • MiyataKNakamuraMKondoMReduction of oscillatory potentials and photopic negative response in patients with autosomal dominant optic atrophy with OPA1 mutationsInvest Ophthalmol Vis Sci20074882082417251483
  • MachidaSGotohYTobaYCorrelation between photopic negative response and retinal nerve fiber layer thickness and optic disc topography in glaucomatous eyesInvest Ophthalmol Vis Sci2008492201220718436853
  • MiyakeYYanagidaKKondoKOtaISubjective scotometry and recording of local electroretinogram and visual evoked response. System with television monitor of the fundusJpn J Ophthalmol198125439448
  • ColottoAFalsiniBSalgarelloTPhotopic negative response of the human ERG: losses associated with glaucomatous damageInvest Ophthalmol Vis Sci2000412205221110892864
  • MachidaSTobaYOhtakiAPhotopic negative response of focal electroretinogram in glaucomatous eyesInvest Ophthalmol Vis Sci2008495636564418641287
  • MachidaSTamadaKOikawaTSensitivity and specificity of photopic negative response of focal electroretinograms in detecting glaucomatous eyesBr J Ophthalmol20109420220819692386
  • MachidaSTamadaKOikawaTComparison of photopic negative response between full-field and focal electroretinograms in detecting glaucomatous eyesJ Ophthalmol9302010 [Epub ahead of print.]
  • KondoMKurimotoYSakaiTRecording focal macular photopic negative response (PhNR) from monkeysInvest Ophthalmol Vis Sci2008493544355018441308
  • TamadaKMachidaSOikawaTCorrelation between photopic negative response of focal electroretinograms and local loss of retinal neurons in glaucomaCurr Eye Res20103515516420136426
  • BhurayanontachaiPRatanasukonMJirarattanasopaPElectrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)Clin Ophthalmol2011556757221607026
  • LükeMJanuschowskiKLükeJEffects of ranibizumab (Lucentis) on retinal function in isolated vertebrate retinaBr J Ophthalmol2009931396140019628500
  • SheybaniABrantleyMAJrApteRSPattern electoretinography in age-related macular degenerationArch Ophthalmol201112958058421555610
  • MafeiLFiorrentiniABistiSHolländerHPattern ERG in the monkey after section of the optic nerveExp Brain Res1985594234254029317
  • MafeiLFiorrentiniAElectroretinographic responses to alternating gratings before and after section of the optic nerveScience19812119539557466369
  • LalwaniGARosenfeldPJFungAEA variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO studyAm J Ophthalmol2009148435819376495
  • KizawaJMachidaSKobayashiTChanges of oscillatory potentials and photopic negative response in patients with early diabetic retinopathyJpn J Ophthalmol20065036737316897223
  • MoschosMMBrouzasDApostolopoulosMIntravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study. Multifocal- ERG after use of bevacizumab in ARMDDoc Ophthalmol2007114374417216267
  • BakriSJSnyderMRReidJMPulidoJSEzzatMKSinghRJPharmacokinetics of intravitreal bevacizumab (Avastin)Ophthalmology200711485585917467524
  • BakriSJSnyderMRReidJMPulidoJSEzzatMKSinghRJPharmacokinetics of intravitreal ranibizumab (Lucentis)Ophthalmology20071142179218218054637
  • HorsleyMBMandavaNMaycotteMAKahookMYRetinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapyAm J Ophthalmol201015055856120643396
  • MachidaSGotohYTanakaMTazawaYPredominant loss of the photopic negative response in central retinal artery occlusionAm J Ophthalmol20043793894015126164
  • ChenHWuDHuangSYanHThe photopic negative response of the flash electroretinogram in retinal vein occlusionDoc Ophthalmol2006113535916944088
  • ChenHZhangMHuangSWuDThe photopic negative response of flash ERG in nonproliferative diabetic retinopathyDoc Ophthalmol200811712913518214565
  • YonemuraDAokiTTsuzukiKElectroretinogram in diabetic retinopathyArch Ophthalmol196268192414009176
  • PapadopoulouDNMedrinosEMangiorisGDonatiGPourarasCJIntravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degenerationOphthalmology20091161755176119560206
  • AmeriHChaderGJKimJGThe effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbitsInvest Ophthalmol Vis Sci2007485708571518055823
  • KimKSChangHRSongSIschemic change after intravitreal bevacizumab (Avastin) injection of macular for macular oedema secondary to non-ischemic central retinal vein occlusionActa Ophthalmol20088692592718494740
  • YokoyamaKChoshiTKimotoKRetinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucomaActa Ophthalmol20088692792818494739
  • ShimuraMYasudaKMacular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular diseaseBr J Ophthalmol20109438138320215378
  • SiliprandiRCanellaRCarmignotoGN-methyl-D-aspartate-induced neurotoxicity in the adult rat retinaVis Neurosci199285675731586655
  • SievingPAFrishmanLJSteinbergRHScotopic threshold response of proximal retina in catJ Neurophysiol198656104910613783228
  • SievingPANinoCScotopic threshold response (STR) of the human electroretinogramInvest Ophthalmol Vis Sci198829160816143182195
  • FrishmanLJShenFFDuLThe scotopic electroretinogram of macaque after retinal ganglion cell loss from experimental glaucomaInvest Ophthalmol Vis Sci1996371251418550316
  • SievingPARetinal ganglion cell loss does not abolish the scotopic threshold response (STR) of the cat and the human ERGClin Vision Sci19916149158